Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Prayer and breathing: a new way to ease dialysis anxiety?

NCT ID NCT07412548

Symptom relief Sponsor: Universitas Muhammadiyah Surakarta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether combining relaxation exercises with listening to a specific Quran chapter (Surah Ar-Rahman) can reduce anxiety and improve sleep in people undergoing kidney dialysis. 76 adult Muslim patients will be split into two groups: one doing the relaxation and Quran therapy, and the other listening to music. Their anxiety, sleep quality, and vital signs will be checked before and after six weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
autogenic relaxation and Quran recitation therapy
What this could lead to
If it works, this could offer a simple, drug-free way to help dialysis patients feel less anxious and sleep better.
What could go wrong
This is a small, early-stage study with only 76 participants, so results may not apply to everyone. The benefits may be due to the extra attention patients receive rather than the therapy itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients diagnosed with stage V chronic kidney disease. 2. Undergoing scheduled hemodialysis at least twice a week for 6 weeks. 3. Outpatients and aged 18-65 years. 4. Muslim. 5. Cooperative and able to communicate verbally. 6. Willing to be a respondent by signing an informed consent form. Exclusion Criteria: 1. Having a severe heart condition or an unstable critical condition. 2. Having a severe psychiatric disorder (schizophrenia, major depression). 3. Having a cognitive, hearing, or speech disorder that impedes communication. 4. Taking antidepressants, anxiolytics, or neuroleptics that may affect psychological measurement results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease - stage V are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder chronic kidney disease end stage renal failure insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease - stage V End-stage renal disease Hemodialysis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Indriati Hospital

    Sukoharjo, Central Java, 57552, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.